Skip to content

Complications in Hypertension and Obesity

National Investigation of Cardiovascular Complications in Arterial Hypertension and Obesity

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00552292
Enrollment
30000
Registered
2007-11-01
Start date
2007-12-31
Completion date
2017-05-31
Last updated
2016-12-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dyslipidemia, Hyperglycemia, Hypertension, Metabolic Syndrome, Obesity

Keywords

metabolic syndrome, hypertension, obesity, dyslipidemia, hyperglycemia, cardiovascular complications

Brief summary

The study in aimed to investigate epidemiology of risk factors in Russian Federation its prognostic value aimed on acceptance of national specific definition of metabolic syndrome and guidelines for its management.

Interventions

None listed

Sponsors

Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Age older 18 years * Signed informed consent * Blood pressure more than 130 and/or 85 mm Hg * Waist circumference more than 80 sm in females and 94 in males and/or BMI more than 25 kg/m2 * Dyslipidemia (elevated TG and/or decreased level of HDLP or therapy for high triglyceride level) * Fasting glucose more than 5,6 mmol/l

Exclusion criteria

* Associated clinical conditions (stroke, TIA, MI, heart failure, renal disease, diabetes mellitus) * Severe concomitant diseases affecting outcome

Design outcomes

Primary

MeasureTime frame
cardiovascular complications2007-2017

Secondary

MeasureTime frame
diabetes mellitus2007-2017

Countries

Russia

Contacts

Primary ContactAlexandra O Conrady, MD, PhD
ahleague@mail.ru+7812-70255-71
Backup ContactElena I Baranova, professor
eibaranova@yahoo.com346-9082

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026